Review



rabbit monoclonal anti atrx  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc rabbit monoclonal anti atrx
    Rabbit Monoclonal Anti Atrx, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Rabbit+mAb/pm41424059-177-4-9
    Average 93 stars, based on 23 article reviews
    rabbit monoclonal anti atrx - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells
    Article Snippet: Antibodies used included anti-ATRX (Cell Signaling, Cat#14820), anti-DAXX (Cell Signaling, Cat#4533), anti-SMARCAL1 (Cell Signaling, Cat#44717) and anti-GAPDH (Santa Cruz, Cat#sc-47724), γH2AX (Cell Signaling, Cat#9718), PML (Santa Cruz, Cat#sc-966).

    Article Title: Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
    Article Snippet: Background.. Telomere maintenance mechanisms are required to enable the replicative immortality of malignant cells.. While most cancers activate the enzyme telomerase, a subset of cancers uses telomerase-independent mechanisms termed alternative lengthening of telomeres (ALT).

    Chromatin Immunoprecipitation:

    Article Title: The HSV-1 encoded CCCTC-binding factor, CTRL2, impacts the nature of viral chromatin during HSV-1 lytic infection.
    Article Snippet: Images were captured with a Zeiss Axiomager Z2 upright fluorescent microscope using ZenPro software. .. ChIP assays were performed for Total H3, H3.3, RNA Polymerase II, CTCF, ATRX, OCT-1 and HCF-1 using their respective specific antibodies as follows: Anti-H3 (EMD Millipore, Cat. No. 04–928), Anti-H3.3 (Abcam, Cat. No. ab176840), Anti-RNAPII (abcam Cat. No. Ab264350), Anti-CTCF (EMD Millipore, Cat. No. 07–729), Anti-ATRX (Cell signaling, PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1012621 October 7, 2024 23 / 28 Ref. No. 14820S), Anti-Oct-1 (Cell signaling, Ref. No. 8157S), and Anti-HCF1 (Cell Signaling, Cat No. 69690). ..

    Article Title: The HSV-1 encoded CCCTC-binding factor, CTRL2, impacts the nature of viral chromatin during HSV-1 lytic infection
    Article Snippet: Images were captured with a Zeiss Axiomager Z2 upright fluorescent microscope using ZenPro software. .. ChIP assays were performed for Total H3, H3.3, RNA Polymerase II, CTCF, ATRX, OCT-1 and HCF-1 using their respective specific antibodies as follows: Anti-H3 (EMD Millipore, Cat. No. 04–928), Anti-H3.3 (Abcam, Cat. No. ab176840), Anti-RNAPII (abcam Cat. No. Ab264350), Anti-CTCF (EMD Millipore, Cat. No. 07–729), Anti-ATRX (Cell signaling, Ref. No. 14820S), Anti-Oct-1 (Cell signaling, Ref. No. 8157S), and Anti-HCF1 (Cell Signaling, Cat No. 69690). ..

    Control:

    Article Title: Directing treatments for glioblastoma based on identifying a somatic structural rearrangement upstream from TERT gene
    Article Snippet: .. Antibodies used included anti-SMARCAL1 (Cell Signaling Technologies), anti-ATRX (Cell Signaling Technologies), anti-β-Actin (Cell Signaling Technologies), and anti-GAPDH (Santa Cruz Biotechnology) for equal loading control. ..

    Western Blot:

    Article Title: Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by ATR Inhibitors
    Article Snippet: Lysates were separated using discontinuous SDS-PAGE to resolve proteins <200kDa or Tris-Acetate gels (NuPAGE, Invitrogen) to resolve proteins >200kDa. .. Antibodies used for immunoblotting were anti-SMARCAL1 (1/100, D3P5I; Cell Signaling), anti-DAXX (1/1000, 25C12; Cell Signaling), anti-ATRX (1/1000, D1N2E; Cell Signaling), anti-ATRX (1/100, sc-55584; Santa Cruz Biotechnology), anti-alpha-tubulin (1/5000, DM1A; Sigma Aldrich) and anti-GAPDH (1/5000, ab9485; Abcam). ..

    Article Title: Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors
    Article Snippet: Lysates were separated using discontinuous SDS-PAGE to resolve proteins of molecular weight < 200 kDa or tris-acetate gels (NuPAGE, Invitrogen) to resolve proteins of molecular weight > 200 kDa. .. Antibodies used for immunoblotting were anti-SMARCAL1 (1/100, D3P5I; Cell Signaling), anti-DAXX (1/1000, 25C12; Cell Signaling), anti-ATRX (1/1000, D1N2E; Cell Signaling), anti-ATRX (1/100, sc-55584; Santa Cruz Biotechnology), anti-alpha-tubulin (1/5000, DM1A; Sigma-Aldrich), and anti-GAPDH (1/5000, ab9485; Abcam). ..



    Similar Products

    94
    Developmental Studies Hybridoma Bank atrx antibodies
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Atrx Antibodies, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/anti-ATRX/bio_rxiv__2025__11__23__689992-242-5-18
    Average 94 stars, based on 1 article reviews
    atrx antibodies - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology atrx
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Atrx, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Antibody/pmc12863253-166-37-39
    Average 95 stars, based on 1 article reviews
    atrx - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology mouse antiatrx
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Mouse Antiatrx, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Antibody/pm41505555-444-89-98
    Average 95 stars, based on 1 article reviews
    mouse antiatrx - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology rabbit anti atrx antibody
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Rabbit Anti Atrx Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Antibody/pm41424059-193-8-11
    Average 95 stars, based on 1 article reviews
    rabbit anti atrx antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rabbit monoclonal anti atrx
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Rabbit Monoclonal Anti Atrx, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Rabbit+mAb/pm41424059-177-4-9
    Average 93 stars, based on 1 article reviews
    rabbit monoclonal anti atrx - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc rabbit anti atrx
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Rabbit Anti Atrx, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/ATRX+Rabbit+mAb/bio_rxiv__2025__11__29__691251-169-52-57
    Average 94 stars, based on 1 article reviews
    rabbit anti atrx - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank pcrp mis18bp1 1b10
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Pcrp Mis18bp1 1b10, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/anti-ATRX/bio_rxiv__2025__11__23__689992-242-17-18
    Average 94 stars, based on 1 article reviews
    pcrp mis18bp1 1b10 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank pcrp atrx 1e4
    (A) Western blot showing depletion of <t>ATRX</t> using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). <t>(B)</t> <t>Immunofluorescence</t> images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.
    Pcrp Atrx 1e4, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+atrx/anti-ATRX/bio_rxiv__2025__11__23__689992-242-20-21
    Average 94 stars, based on 1 article reviews
    pcrp atrx 1e4 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Western blot showing depletion of ATRX using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). (B) Immunofluorescence images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.

    Journal: bioRxiv

    Article Title: ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

    doi: 10.1101/2025.11.23.689992

    Figure Lengend Snippet: (A) Western blot showing depletion of ATRX using CRISPR and sgRNA targeting ATRX or a non-targeting control sequence (NTC). (B) Immunofluorescence images of ATRX depletion. (C-E) Growth curves showing cell counts over time with ATRX knockout in HUtSMC (C), BJ (D), and HDF (E). (F) Western blots showing dual knockout of ATRX and TP53 in HUtSMC cells. (G-I) Growth curves over time showing HUtSMC cell number (G) or percent confluence for BJ (H) and HDF (I). *P value < 0.05; **P value < 0.01; ***P value < 0.001. Scale bars = 10 μm.

    Article Snippet: We also tested the following ATRX antibodies but did not have success by western blotting and immunofluorescence: PCRP-MIS18BP1-1B10 (DSHB) and PCRP-ATRX-1E4 (DSHB).

    Techniques: Western Blot, CRISPR, Control, Sequencing, Immunofluorescence, Knock-Out

    (A) Western blotting for ATRX in UPS cell lines. Two different clones were used for each cell line. P indicates parental control and NT indicates expression of a non-targeting control sgRNA. (B) Representative images from colony formation assay. Quantification of crystal violet is shown in the adjacent bar graphs. (C) Representative images from migration assay. Quantification of migrating cells shown in the adjacent bar graphs. (D) Representative images from invasion assay. Quantification of invading cells shown in the adjacent bar graphs. (E) UPS cells were xenografted into immunodeficient mice, and tumor volume was measured over time. (F) Image of explanted tumors at the end of the xenograft experiment. Bars represent means ± SD, and significance is indicated as follows: *P < 0.05, **P < 0.01.

    Journal: bioRxiv

    Article Title: ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

    doi: 10.1101/2025.11.23.689992

    Figure Lengend Snippet: (A) Western blotting for ATRX in UPS cell lines. Two different clones were used for each cell line. P indicates parental control and NT indicates expression of a non-targeting control sgRNA. (B) Representative images from colony formation assay. Quantification of crystal violet is shown in the adjacent bar graphs. (C) Representative images from migration assay. Quantification of migrating cells shown in the adjacent bar graphs. (D) Representative images from invasion assay. Quantification of invading cells shown in the adjacent bar graphs. (E) UPS cells were xenografted into immunodeficient mice, and tumor volume was measured over time. (F) Image of explanted tumors at the end of the xenograft experiment. Bars represent means ± SD, and significance is indicated as follows: *P < 0.05, **P < 0.01.

    Article Snippet: We also tested the following ATRX antibodies but did not have success by western blotting and immunofluorescence: PCRP-MIS18BP1-1B10 (DSHB) and PCRP-ATRX-1E4 (DSHB).

    Techniques: Western Blot, Clone Assay, Control, Expressing, Colony Assay, Migration, Invasion Assay